BDTX
NASDAQ · Biotechnology
Black Diamond Therapeutics I
$1.83
-0.05 (-2.66%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,862.8% upside
Low Target
$30.62
Average Target
$35.92
High Target
$44.24
Current Price
$1.83
Current
$1.83
$1.83
Target
$35.92
$35.92
$30.62
$35.92 avg
$44.24
Scenario Analysis
Bear Case
$30.62
1,573.2%
Low target
Base Case
$35.92
+1,862.8%
Avg target
Bull Case
$44.24
+2,317.5%
High target
Risk/Reward
1.5x
Balanced
Price in Context
52-Week High
$4.94
-63.0% from high
52-Week Low
$1.60
+14.4% from low
Target vs 52W High
$35.92
+627.1% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -3.3% |
| AMGN | Hold | 43 | 47% | $190.87 | -54.4% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +138.3% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -16.9% |
| REGN | Buy | 38 | 68% | $76.80 | -89.8% |
| MRNA | Hold | 30 | 37% | $149.45 | -24.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -65.3% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -43.4% |